Clinically meaningful efficacy of a non-estrogen agent: re-analysis of phase-2 data evaluating MF101.Published in:Climacteric, 2012, v. 15, n. 6, p. 607, doi. 10.3109/13697137.2011.630113By:Tagliaferri, M.;Creasman, J.;Caygill, K. A.;Olyaie, A.;Leitman, D.;Cohen, I.;Grady, D.Publication type:Article
The 5% difference: early sensory processing predicts sarcasm perception in schizophrenia and schizo-affective disorder.Published in:Psychological Medicine, 2014, v. 44, n. 1, p. 25, doi. 10.1017/S0033291713000834By:Kantrowitz, J. T.;Hoptman, M. J.;Leitman, D. I.;Silipo, G.;Javitt, D. C.Publication type:Article